Literature DB >> 2764376

Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease.

M Donahoe1, R M Rogers, D O Wilson, B E Pennock.   

Abstract

Patients with severe chronic obstructive pulmonary disease (COPD) commonly experience weight loss. An increased energy expenditure for respiration might explain the increased caloric requirements and weight loss seen in this patient population. We measured the oxygen cost of augmenting ventilation (O2 cost) using an open circuit technique with dead-space stimulation of ventilation in nine normally nourished (greater than 90% ideal body weight) and in 10 malnourished (less than 90% ideal body weight) patients with COPD as well as in seven normal control subjects. O2 cost was significantly elevated in the malnourished patients with COPD (4.28 +/- 0.98 ml O2/L ventilation) relative to the normally nourished group (2.61 +/- 1.07) and the normal control subjects (1.23 +/- 0.51) (p less than 0.001). The measured resting energy expenditure (REEmeas) was also increased compared with predicted values (REEpred) in the malnourished population (REEmeas/REEpred = 94.57 +/- 6.21% for control subjects, 105.5 +/- 19.66% for normally nourished patients with COPD, and 119.4 +/- 11.69% for malnourished patients with COPD) (p less than 0.005). The malnourished population was characterized by a greater degree of hyperinflation (RV/TLC = 0.55 +/- 0.09 for normally nourished versus 0.69 +/- 0.06 for malnourished patients) and inspiratory muscle weakness (PImax = 51 +/- 16.5 for the normally nourished and 34 +/- 12.2 for the malnourished population). We conclude that malnourished patients with COPD are characterized by a relative increase in resting energy requirements and, specifically, increased energy requirements for augmenting ventilation. This increase in energy requirements may result from the increased mechanical work load associated with severe COPD and/or a reduced ventilatory muscle efficiency.

Entities:  

Mesh:

Year:  1989        PMID: 2764376     DOI: 10.1164/ajrccm/140.2.385

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  25 in total

1.  Nutritional support in chronic obstructive lung disease.

Authors:  J W Fitting
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

2.  Effect of chronic airflow limitation on resting oxygen consumption.

Authors:  C Lanigan; J Moxham; J Ponte
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

3.  Label-free oxygen-metabolic photoacoustic microscopy in vivo.

Authors:  Junjie Yao; Konstantin I Maslov; Yu Zhang; Younan Xia; Lihong V Wang
Journal:  J Biomed Opt       Date:  2011-07       Impact factor: 3.170

Review 4.  Defining COPD-Related Comorbidities, 2004-2014.

Authors:  Carlos H Martinez; David M Mannino; Miguel J Divo
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

Review 5.  Nutritional aspects of chronic obstructive pulmonary disease.

Authors:  Daniel A King; Francis Cordova; Steven M Scharf
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Lung function, breathing pattern, and gas exchange in interstitial lung disease.

Authors:  S Javaheri; L Sicilian
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

8.  Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty.

Authors:  M K Sridhar; R Carter; M E Lean; S W Banham
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

9.  Body composition and exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; R Mostert; P B Soeters; E F Wouters
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.